| 1. |
- Benson, Mikael, et al.
(author)
-
Interleukin (IL)-6 and IL-8 in children with febrile urinary tract infection and asymptomatic bacteriuria
- 1996
-
In: Journal of Infectious Diseases. - : Oxford University Press (OUP). - 0022-1899 .- 1537-6613. ; 174:5, s. 1080-1084
-
Journal article (peer-reviewed)abstract
- Urine and serum interleukin (IL)-6 and IL-8 responses were higher in children with febrile urinary tract infection (n = 61) than in those with asymptomatic bacteriuria (n = 39). By univariate analysis, cytokine levels were related to age, sex, reflux, renal scarring, urine leukocytes, C- reactive protein (CRP), erythrocyte sedimentation rate (ESR), and bacterial properties (P fimbriae but not hemolysin). Multivariate modeling showed that urine IL-6 responds were higher in girls than boys, increased with age, and were positively associated with CRP, ESR, serum IL-6, and urine leukocyte counts. The urine IL-8 response was not influenced by age, but it was influenced by P fimbriae and was associated with ESR, CRP, urine leukocytes, and female sex. The results show that cytokine responses to urinary tract infection vary with the severity of infection and that cytokine activation is influenced by a variety of host and bacterial variables.
|
|
| 2. |
- Gustavsson, Anders, et al.
(author)
-
Cost of disorders of the brain in Europe 2010.
- 2011
-
In: European Neuropsychopharmacology. - Amsterdam : Elsevier BV. - 0924-977X .- 1873-7862. ; 21:10, s. 718-79
-
Journal article (peer-reviewed)abstract
- BACKGROUND: The spectrum of disorders of the brain is large, covering hundreds of disorders that are listed in either the mental or neurological disorder chapters of the established international diagnostic classification systems. These disorders have a high prevalence as well as short- and long-term impairments and disabilities. Therefore they are an emotional, financial and social burden to the patients, their families and their social network. In a 2005 landmark study, we estimated for the first time the annual cost of 12 major groups of disorders of the brain in Europe and gave a conservative estimate of €386 billion for the year 2004. This estimate was limited in scope and conservative due to the lack of sufficiently comprehensive epidemiological and/or economic data on several important diagnostic groups. We are now in a position to substantially improve and revise the 2004 estimates. In the present report we cover 19 major groups of disorders, 7 more than previously, of an increased range of age groups and more cost items. We therefore present much improved cost estimates. Our revised estimates also now include the new EU member states, and hence a population of 514 million people.AIMS: To estimate the number of persons with defined disorders of the brain in Europe in 2010, the total cost per person related to each disease in terms of direct and indirect costs, and an estimate of the total cost per disorder and country.METHODS: The best available estimates of the prevalence and cost per person for 19 groups of disorders of the brain (covering well over 100 specific disorders) were identified via a systematic review of the published literature. Together with the twelve disorders included in 2004, the following range of mental and neurologic groups of disorders is covered: addictive disorders, affective disorders, anxiety disorders, brain tumor, childhood and adolescent disorders (developmental disorders), dementia, eating disorders, epilepsy, mental retardation, migraine, multiple sclerosis, neuromuscular disorders, Parkinson's disease, personality disorders, psychotic disorders, sleep disorders, somatoform disorders, stroke, and traumatic brain injury. Epidemiologic panels were charged to complete the literature review for each disorder in order to estimate the 12-month prevalence, and health economic panels were charged to estimate best cost-estimates. A cost model was developed to combine the epidemiologic and economic data and estimate the total cost of each disorder in each of 30 European countries (EU27+Iceland, Norway and Switzerland). The cost model was populated with national statistics from Eurostat to adjust all costs to 2010 values, converting all local currencies to Euro, imputing costs for countries where no data were available, and aggregating country estimates to purchasing power parity adjusted estimates for the total cost of disorders of the brain in Europe 2010.RESULTS: The total cost of disorders of the brain was estimated at €798 billion in 2010. Direct costs constitute the majority of costs (37% direct healthcare costs and 23% direct non-medical costs) whereas the remaining 40% were indirect costs associated with patients' production losses. On average, the estimated cost per person with a disorder of the brain in Europe ranged between €285 for headache and €30,000 for neuromuscular disorders. The European per capita cost of disorders of the brain was €1550 on average but varied by country. The cost (in billion €PPP 2010) of the disorders of the brain included in this study was as follows: addiction: €65.7; anxiety disorders: €74.4; brain tumor: €5.2; child/adolescent disorders: €21.3; dementia: €105.2; eating disorders: €0.8; epilepsy: €13.8; headache: €43.5; mental retardation: €43.3; mood disorders: €113.4; multiple sclerosis: €14.6; neuromuscular disorders: €7.7; Parkinson's disease: €13.9; personality disorders: €27.3; psychotic disorders: €93.9; sleep disorders: €35.4; somatoform disorder: €21.2; stroke: €64.1; traumatic brain injury: €33.0. It should be noted that the revised estimate of those disorders included in the previous 2004 report constituted €477 billion, by and large confirming our previous study results after considering the inflation and population increase since 2004. Further, our results were consistent with administrative data on the health care expenditure in Europe, and comparable to previous studies on the cost of specific disorders in Europe. Our estimates were lower than comparable estimates from the US.DISCUSSION: This study was based on the best currently available data in Europe and our model enabled extrapolation to countries where no data could be found. Still, the scarcity of data is an important source of uncertainty in our estimates and may imply over- or underestimations in some disorders and countries. Even though this review included many disorders, diagnoses, age groups and cost items that were omitted in 2004, there are still remaining disorders that could not be included due to limitations in the available data. We therefore consider our estimate of the total cost of the disorders of the brain in Europe to be conservative. In terms of the health economic burden outlined in this report, disorders of the brain likely constitute the number one economic challenge for European health care, now and in the future. Data presented in this report should be considered by all stakeholder groups, including policy makers, industry and patient advocacy groups, to reconsider the current science, research and public health agenda and define a coordinated plan of action of various levels to address the associated challenges.RECOMMENDATIONS: Political action is required in light of the present high cost of disorders of the brain. Funding of brain research must be increased; care for patients with brain disorders as well as teaching at medical schools and other health related educations must be quantitatively and qualitatively improved, including psychological treatments. The current move of the pharmaceutical industry away from brain related indications must be halted and reversed. Continued research into the cost of the many disorders not included in the present study is warranted. It is essential that not only the EU but also the national governments forcefully support these initiatives.
|
|
| 3. |
- Guzzi, Nicola, et al.
(author)
-
Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells
- 2018
-
In: Cell. - : Elsevier BV. - 0092-8674 .- 1097-4172. ; 173:5, s. 26-1216
-
Journal article (peer-reviewed)abstract
- Pseudouridylation (Ψ) is the most abundant and widespread type of RNA epigenetic modification in living organisms; however, the biological role of Ψ remains poorly understood. Here, we show that a Ψ-driven posttranscriptional program steers translation control to impact stem cell commitment during early embryogenesis. Mechanistically, the Ψ “writer” PUS7 modifies and activates a novel network of tRNA-derived small fragments (tRFs) targeting the translation initiation complex. PUS7 inactivation in embryonic stem cells impairs tRF-mediated translation regulation, leading to increased protein biosynthesis and defective germ layer specification. Remarkably, dysregulation of this posttranscriptional regulatory circuitry impairs hematopoietic stem cell commitment and is common to aggressive subtypes of human myelodysplastic syndromes. Our findings unveil a critical function of Ψ in directing translation control in stem cells with important implications for development and disease. Translational control in stem cells is orchestrated by pseudouridylation of specific tRNA-derived fragments, impacting stem cell commitment during key developmental processes.
|
|
| 4. |
- Abubaker, Jamal, et al.
(author)
-
Short-Term Effects of Biogas Digestates and Pig Slurry Application on Soil Microbial Activity
- 2015
-
In: Applied and Environmental Soil Science. - : Hindawi Limited. - 1687-7667 .- 1687-7675. ; 2015, s. 1-15
-
Journal article (peer-reviewed)abstract
- The effect of four biogas digestates (BD-A, BD-B, BD-C, and BD-D) and pig slurry (PS) on soil microbial functions was assessed at application rates corresponding to 0–1120 kg-N ha−1. At dose corresponding to 140 kg-N ha−1, 30.9–32.5% of the carbon applied in BD-A, BD-C, and PS was utilized during 12 days, while for BD-B and BD-D corresponding utilization was 19.0 and 16.9%, respectively. All BDs resulted in net nitrogen assimilation at low rates (17.5–140 kg-N ha−1) but net mineralization dominated at higher rates. PS resulted in net mineralization at all application rates. All residues inhibited potential ammonium oxidation (PAO), with EC50-values ranging between 45 and 302 kg-N ha−1. Low rates of BDs appeared to weakly stimulate potential denitrification activity (PDA), while higher rates resulted in logarithmic decrease. The EC50-values for PDA were between 238 and 347 kg-N ha−1. No inhibition of PDA was observed after amendment with PS. In conclusion, biogas digestates inhibited ammonia oxidation and denitrification, which could be an early warning of potential hazardous substances in the digestates. However, this effect can also be regarded as positive, since it may reduce nitrogen losses.
|
|
| 5. |
- Al-Najjar, Basim, 1954-, et al.
(author)
-
Pre-Study : Info & technology needed for Cloud based smart sustainable integrated production-maintenance system
- 2021
-
Reports (peer-reviewed)abstract
- The project had several objectives, such as gathering and preparing the required information to highlight the problems and challenges experienced by the factories of AstraZeneca (AZ) and Ericsson in India and Sweden: Identifying the knowledge, tools, and technologies that are necessary for solving/meeting the problems/challenges experienced by these factories: Preparing for a new joint project, Smart sustainable integrated production-maintenance (Smart-Pro) system: and identifying additional Indians partners in the spirit of the collaboration between Sweden and India.The project consisted of three WPs (WP1, WP2 and WP3) which were interdependent. WP1 was responsible of management, administration, supporting WPs, transferring knowledge and experience between WPs, develop a conceptual model and the final reports.WP2 responsibilities were identifying the problems/challenges experienced as well as new Indian partners. Therefore, WP2 started by gathering the information needed for the analysis of the production and maintenance processes at the factories. WP3 was responsible of identifying the knowledge, tools and technologies needed to solve/meet the problems/challenges identified by WP2. The planned objectives of WP2 and WP3 have been achieved and reported.Based on the achieved results by WP2 and WP3, WP1 developed a conceptual model describing Smart-Pro system for effective production planning, scheduling, follow up and decision making. In addition, it is also described a Plug-and-Play solution for automatic detection-localizing of damages, damage severity estimation, predicting damage development, recommending what, where and when to act cost-effectively to maintain production process quality.
|
|
| 6. |
- Al-Najjar, Basim, 1954-, et al.
(author)
-
Technologies needed for Smart Pro meeting industrial challenges and problems
- 2021
-
Reports (peer-reviewed)abstract
- The major goal of the pre-study is to identify and prepare the required information, knowledge, tools, modules, and technologies for a project within Smart Manufacturing in the spirit of the collaboration between Sweden and India.WP3 focus is: Identification of the technologies needed to be considered in Smart-Pro project as an Innovation action. This means that the input technologies that will be identified in the Pre-study project should be in about TRL 3-, and the demonstrated results of Smart-Pro should be in about TRL 6-7. Smart Pro project will be based on effective collaboration between universities/research institutes and industry.In WP3, we will develop a list of the tools, methods, modules and technologies (in the areas below) which are available at the members of the Pre-study consortium (and in industry in general), and necessary for developing Smart-Pro system.According to the project description, WP3 has two Tasks:• T3.1: Production-maintenance technologies needed for Smart-Pro.• T3.2: Communication and integration technologies needed for Smart-Pro.The tasks have been distributed between E-maintenance AB (Emaint), which the leader of the WP and the two tasks, Linnaeus University (LNU), Uppsala University (UU) and Stockholm University (SU).
|
|
| 7. |
- Alevanau, Aliaksandr, 1965-, et al.
(author)
-
Mechanically assisted low temperature pyrolysis of hydrocarbons
- 2014
-
In: Proceedings of the XVII International Conference Foundations & Advances in Nonlinear Science, September 29 - October 3, Minsk 2014.
-
Conference paper (peer-reviewed)abstract
- We report experimental setups and conditions leading to pyrolysis (cracking) of such gaseous hydrocarbons as methane, mixed propane and butane, at the temper-atures of the heater below 200oC. The process was mechanically assisted by putting the substances being decomposed into a dynamic interaction with the tin and bismuth alloy. The alloy had periodically changing phase state thus creating fractal interfaces between its surface and the gases. Interaction of the gases with mechanically produced fractal surfaces of the alloy made possible gas decomposition even at lower temperatures of the heater (150oC). At this temperature the heater couldn't melt the alloy in the heated volume with the gas.
|
|
| 8. |
- Alevanau, Aliaksandr, 1965-
(author)
-
Study of pyrolysis and gasification of biomass from the self-organization perspective
- 2015
-
Doctoral thesis (other academic/artistic)abstract
- This thesis focuses on the analysis of kinetics of i) low-temperature pyrolysis of gaseous hydrocarbons, ii) high-temperature steam gasification of char of wood pellets (>700oC), iii) high temperature pyrolysis of straw pellets in an atmosphere of argon and steam, and iv) high temperature pyrolysis of slices of transversally cut wooden sticks. The results of the kinetic measurements in the high-temperature cases are approximated using a least-square based optimization software, which was specially developed to analyse kinetics prone for deviation from the Arrhenius law.In the thesis a general analysis of the researched materials and kinetics of their pyrolysis and gasification is presented from the self-organization perspective. The energy transfer phenomena in both the pyrolysis and gasification processes of biomass are discussed with an emphasis on an analysis of basic phenomena involving the self-organized dynamics on fractal structures in the chosen biomass samples.
|
|
| 9. |
|
|
| 10. |
- Anand, Vibha, et al.
(author)
-
Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes : Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S
- 2021
-
In: Diabetes Care. - : American Diabetes Association. - 1935-5548 .- 0149-5992. ; 44, s. 2269-2276
-
Journal article (peer-reviewed)abstract
- OBJECTIVE: To combine prospective cohort studies, by including HLA harmonization, and estimate risk of islet autoimmunity and progression to clinical diabetes.RESEARCH DESIGN AND METHODS: For prospective cohorts in Finland, Germany, Sweden, and the U.S., 24,662 children at increased genetic risk for development of islet autoantibodies and type 1 diabetes have been followed. Following harmonization, the outcomes were analyzed in 16,709 infants-toddlers enrolled by age 2.5 years.RESULTS: In the infant-toddler cohort, 1,413 (8.5%) developed at least one autoantibody confirmed at two or more consecutive visits (seroconversion), 865 (5%) developed multiple autoantibodies, and 655 (4%) progressed to diabetes. The 15-year cumulative incidence of diabetes varied in children with one, two, or three autoantibodies at seroconversion: 45% (95% CI 40-52), 85% (78-90), and 92% (85-97), respectively. Among those with a single autoantibody, status 2 years after seroconversion predicted diabetes risk: 12% (10-25) if reverting to autoantibody negative, 30% (20-40) if retaining a single autoantibody, and 82% (80-95) if developing multiple autoantibodies. HLA-DR-DQ affected the risk of confirmed seroconversion and progression to diabetes in children with stable single-autoantibody status. Their 15-year diabetes incidence for higher- versus lower-risk genotypes was 40% (28-50) vs. 12% (5-38). The rate of progression to diabetes was inversely related to age at development of multiple autoantibodies, ranging from 20% per year to 6% per year in children developing multipositivity in ≤2 years or >7.4 years, respectively.CONCLUSIONS: The number of islet autoantibodies at seroconversion reliably predicts 15-year type 1 diabetes risk. In children retaining a single autoantibody, HLA-DR-DQ genotypes can further refine risk of progression.
|
|
